PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-65.89%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-75.27%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-143.06%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-144.21%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-146.51%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-146.81%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-146.81%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
0.00%
Diluted share change of 0.00% while 5715.T is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-86.04%
Negative 10Y revenue/share CAGR while 5715.T stands at 22.59%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-37.58%
Negative 5Y CAGR while 5715.T stands at 6.73%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-6.46%
Negative 3Y CAGR while 5715.T stands at 0.13%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
Positive long-term OCF/share growth while 5715.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
91.24%
Below 50% of 5715.T's 284.62%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
57.94%
Below 50% of 5715.T's 2817.87%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-150.33%
Negative 3Y CAGR while 5715.T is 18.52%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
208.94%
5Y equity/share CAGR above 1.5x 5715.T's 40.56%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
15.17%
3Y equity/share CAGR at 50-75% of 5715.T's 23.93%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-28.25%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
44.95%
Inventory growth well above 5715.T's 9.25%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.40%
Asset growth above 1.5x 5715.T's 0.60%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-4.48%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
45.19%
Debt growth far above 5715.T's 0.33%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
35.66%
SG&A growth well above 5715.T's 59.98%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.